MEDICINES CO's ticker is and the CUSIP is 584688AG0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $68,404,000 | -18.3% | 90,166,000 | -1.7% | 1.82% | +48.3% |
| Q3 2018 | $83,675,000 | +83.4% | 91,758,000 | +103.2% | 1.23% | +71.5% |
| Q2 2018 | $45,634,000 | +33.8% | 45,161,000 | +27.8% | 0.72% | +3.2% |
| Q1 2018 | $34,109,000 | +7.6% | 35,342,000 | +2.5% | 0.69% | -7.8% |
| Q4 2017 | $31,692,000 | +1.9% | 34,471,000 | +17.1% | 0.75% | +23.1% |
| Q3 2017 | $31,098,000 | +10.1% | 29,442,000 | +9.6% | 0.61% | -19.7% |
| Q2 2017 | $28,247,000 | – | 26,870,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 3,000,000 | $2,762,000 | 2.59% |
| PT ASSET MANAGEMENT, LLC | 3,750,000 | $3,448,000 | 1.87% |
| ARISTEIA CAPITAL, L.L.C. | 32,500,000 | $29,921,000 | 1.27% |
| ZAZOVE ASSOCIATES LLC | 22,710,000 | $20,905,000 | 1.23% |
| PFM Health Sciences, LP | 34,471,000 | $31,692,000 | 0.75% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 24,215,000 | $22,262,000 | 0.63% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 36,000,000 | $33,075,000,000 | 0.59% |
| Partner Investment Management, L.P. | 479,000 | $440,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 4,808,000 | $4,398,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,315,000 | $29,732,000 | 0.30% |